Hardik Shah
2026.05.21 10:47

๐Ÿ“ข ๐‰๐”๐’๐“ ๐ˆ๐: Eli Lillyโ€™s Retatrutide Shows Up to ๐Ÿ‘๐ŸŽ.๐Ÿ‘% Weight Loss in Phase 3 Trial - $Eli Lilly(LLY.US) $Novo Nordisk AS(NVO.US) $Hims & Hers Health(HIMS.US)

๐Ÿ‘‰ ๐Š๐ž๐ฒ ๐‡๐ข๐ ๐ก๐ฅ๐ข๐ ๐ก๐ญ๐ฌ:

โžค Lillyโ€™s ๐ซ๐ž๐ญ๐š๐ญ๐ซ๐ฎ๐ญ๐ข๐๐ž achieved up to ๐Ÿ๐Ÿ–.๐Ÿ‘% weight loss over ๐Ÿ–๐ŸŽ weeks.

โžค Highest ๐Ÿ๐Ÿ ๐ฆ๐  dose delivered average loss of ๐Ÿ•๐ŸŽ.๐Ÿ‘ pounds.

โžค ๐Ÿ’๐Ÿ“.๐Ÿ‘% of participants lost ๐Ÿ‘๐ŸŽ% or more body weight.

โžค Extension study showed up to ๐Ÿ‘๐ŸŽ.๐Ÿ‘% weight loss after ๐Ÿ๐ŸŽ๐Ÿ’ weeks.

โžค ๐Ÿ”๐Ÿ“.๐Ÿ‘% of patients on ๐Ÿ๐Ÿ ๐ฆ๐  moved below obesity-level BMI.

โžค Common side effects included ๐ง๐š๐ฎ๐ฌ๐ž๐š, diarrhea, constipation, and vomiting.

โžค Retatrutide targets ๐†๐ˆ๐, ๐†๐‹๐-๐Ÿ, and glucagon hormone receptors.

The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.